Defendant Name:
Bausch Health Companies, Inc.
Defendant Type:
Public Company
SIC Code:
2834
CUSIP:
07173410
Document Reference:
33-10809
Document Details
Legal Case Name
In the Matter of Valeant Pharmaceuticals International, Inc., n/k/a Bausch Health Companies Inc.
Document Name
Order Instituting Cease-and-Desist Proceeding Pursuant to Section 8A of the Securities Act of 1933 and Section 21C of the Securities Exchange Act of 1934, Making Findings, and Imposing a Cease-and-Desist Order
Document Date
31-Jul-2020
Document Format
Administrative Proceeding
AAER
4153
Allegation Type
Issuer Reporting and Disclosure
Document Summary
On July 31, 2020, the SEC instituted settled cease-and-desist proceedings against Valeant Pharmaceuticals International, Inc., now known as Bausch Health Companies Inc. The SEC stated: "When announcing certain GAAP and non-GAAP financial measures, Valeant failed to disclose to investors certain material information about these measures."
Disgorgement & Penalty Information
Resolutions
Cease and Desist Order
Cooperation Before the Resolution
Remedial Acts or Efforts Before the Resolution
Fair Funds
Monetary Penalties:
Civil Penalty
Individual:
$45,000,000.00
Shared: